Create Account

One Health helps you track and understand your health simply.

Create Account

One Health helps you track and understand your health simply.

Bilirubin Direct

Liver & Biliary

Conjugated bilirubinDBILDirect bili

Review status

Currently under review

Pending specialist review and validation.

What it shows

Bilirubin direct measures the conjugated portion of bilirubin in your blood. After bilirubin is processed by the liver, it becomes water soluble so it can be carried in bile and removed through the intestines.

This test helps show how well your liver is processing and moving bile.

Why it matters

Clinicians order direct bilirubin when you have yellowing of the skin or eyes, dark urine, pale stools, right upper belly pain, or abnormal liver tests. It helps distinguish problems in the liver from problems in the bile ducts, and supports evaluation of gallstones, hepatitis, medication effects, and inherited conditions.

It is also used to monitor known liver or biliary disease and to track recovery after treatment or surgery. Interpreting it with total bilirubin and other liver markers can guide next steps, such as imaging, medication changes, or specialist referral.

Understanding your results

If your result is higher than expected, it often points toward reduced bile flow or blockage, or liver cell injury that impairs the movement of conjugated bilirubin. Your clinician will interpret it together with total bilirubin and other markers such as ALT, AST, alkaline phosphatase, and GGT, plus your symptoms and imaging if needed. Lower than expected values are usually not concerning. If the result does not fit how you feel, repeat testing may be suggested to confirm.

Based on your history, you may be asked to avoid alcohol, review medications and supplements, and check for viral hepatitis or autoimmune disease. Seek urgent care if you develop worsening jaundice, fever, severe abdominal pain, confusion, or bleeding, as these can signal complications that need prompt attention.

Reference ranges

07.3 umol/L
All sexes
0 days – 15 days
03 umol/L
All sexes
15 days – 1 year
01.9 umol/L
All sexes
1 year – 9 years
02.9 umol/L
All sexes
9 years – 13 years
1.78.6 umol/L
All sexes
13 years – 18 years
1.78.6 umol/L
All sexes
18 years – 150 years

Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.

Factors that could impact Bilirubin Direct

  • Sample handling and light exposure

    Bilirubin can degrade with prolonged light exposure or delayed separation of serum from cells, which may lower results or cause variability. Proper protection from light and timely processing reduce preanalytic error.

  • Fasting, meals, and hydration

    Fasting is not required, but large fatty meals or dehydration can influence bile flow and liver enzymes, which may subtly affect interpretation of direct bilirubin.

  • Medications and supplements

    Drugs that affect bile transport or liver enzymes, such as certain antivirals, anabolic steroids, estrogen therapies, and some antibiotics, can raise direct bilirubin. High dose vitamin C and other antioxidants may interfere with some assays.

  • Alcohol and concurrent liver disease

    Recent alcohol use, viral hepatitis, fatty liver disease, and biliary obstruction can increase direct bilirubin by impairing processing or flow of conjugated pigment.

  • Hemolysis and lab interference

    A visibly hemolyzed sample can alter measurements and interfere with color based methods. If the report notes hemolysis, your clinician may repeat the test.

  • Age, pregnancy, and inherited conditions

    Newborns, infants, pregnant people, and those with disorders like Dubin Johnson or Rotor syndrome can show different patterns. Age and pregnancy status guide interpretation.

2026

References

  1. McGill University Health Centre. (2016, July 28). Bilirubin Direct (Task CD 316046). Laboratory reference ranges.
  2. Kwo, P. Y., Cohen, S. M., & Lim, J. K. (2017). ACG clinical guideline: Evaluation of abnormal liver chemistries. The American Journal of Gastroenterology, 112(1), 18-35. External link
  3. American Association for the Study of Liver Diseases. (2021). How to approach elevated liver enzymes. Liver Fellow Network. External link